Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature (Q38638685)

5 September 2017

title

Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature (English)

1 reference

5 September 2017

main subject

Prader–Willi syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

D Cohen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

D Thuilleaux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

A Consoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

S Cabal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

M Tauber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

publication date

19 November 2015

1 reference

European Journal of Pediatrics

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

volume

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

9-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26584571 AND SRC:MED&resulttype=core&format=json

Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Prader-Willi syndrome: medical prevention and behavioral challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Naltrexone and fluoxetine in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Mathematical skills in Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Prader–Willi syndrome and Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Effects of growth hormone treatment in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Prader-Willi syndrome and psychotic symptoms: 2. A preliminary study of prevalence using the Psychopathology Assessment Schedule for Adults with Developmental Disability checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

The use of fluoxetine in an adolescent with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Effectiveness of antipsychotic medication in people with intellectual disability and schizophrenia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Risperidone in treating behavioural disturbances of Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Recommendations for the diagnosis and management of Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Effects of mazindol in two patients with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

CNS adverse events associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Acute psychotic symptoms induced by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Tryptophan for the treatment of excessive daytime sleepiness in Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Pediatric case report of topiramate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Review and meta-analysis of pharmacotherapy for binge-eating disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Genetics and mathematics: evidence from Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Effects of topiramate in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Psychiatric illness in a cohort of adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Topiramate effectiveness in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Emotional symptoms in Prader-Willi syndrome adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Academic underachievement by people with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

Acute psychotic disorders induced by topiramate: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00431-015-2670-X

An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome

21 January 2018

1 reference

12 December 2020

Food Intake in Prader‐Willi Syndrome and Controls with Obesity After Administration of a Benzodiazepine Receptor Agonist

1 reference

12 December 2020

N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice

1 reference

12 December 2020

Failure of fluoxetine to modify the skin‐picking behaviour of Prader‐Willi syndrome

1 reference

12 December 2020

Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities

1 reference

12 December 2020

Expressive language in persons with Prader-Willi syndrome

1 reference

12 December 2020

Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome

1 reference

12 December 2020

Risperidone in Prader-Willi syndrome

1 reference

12 December 2020

The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome

1 reference

12 December 2020

Psychosis associated with fluoxetine in Prader-Willi syndrome

1 reference

12 December 2020

Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome

1 reference

12 December 2020

[Efficacy of topiramate in children and adolescent with problems in impulse control: preliminary results]

1 reference

12 December 2020

Mental health problems in children with prader-willi syndrome

1 reference

12 December 2020

Effect of naloxone on hyperphagia in Prader-Willi syndrome

1 reference

12 December 2020

Auditory hallucinations associated with topiramate

1 reference

12 December 2020

Acute psychotic disorders induced by topiramate: report of two cases

1 reference

12 December 2020

Affective psychosis and Prader-Willi syndrome

1 reference

12 December 2020

Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome

1 reference

12 December 2020

Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour

1 reference

12 December 2020